Author:
Boulanger Renaud F.,Komparic Ana,Dawson Angus,Upshur Ross E. G.,Silva Diego S.
Funder
Canadian Institutes of Health Research
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Health(social science)
Reference26 articles.
1. Albert, H., R.R. Nathavitharana, C. Isaacs, M. Pai, C.M. Denkinger, and C.C. Boehme. 2016. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: What lessons have we learnt and how can we do better? European Respiratory Journal 48(2): 516–525.
2. Boulanger, R.F., S. Seidel, E. Lessem, et al. 2013. Engaging communities in tuberculosis research. Lancet Infectious Diseases 13(6): 540–545.
3. Braun, V., and V. Clarke. 2006. Using thematic analysis in psychology. Qualitative Research in Psychology 3(2): 77–101.
4. Churchyard, G.J., W.S. Stevens, L.D. Mametja, et al. 2015. Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: A cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF. Lancet Global Health 3(8): e450-e457.
5. Clayden, P., S. Collins, M. Frick, et al. 2016. The 2016 Pipeline Report: HIV and Tuberculosis (TB) drugs, diagnostics, vaccines, preventive technologies, research towards a cure, and immune-based and gene therapies in development. London/New York: Treatment Action Group.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献